lyophilization raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-07-16 and is reviewed periodically as new material appears.
化学修饰延长了分子在体内的停留时间,使较低频次的给药安排成为可能。脂肪酸侧链通过与白蛋白结合延缓清除,非天然氨基酸则降低酶解速率。这些修饰同时改变分子的溶解性与稳定性,需要在制剂设计和储存条件中一并考虑。修饰引入的免疫原性风险也属于开发过程中需要评估的项目。
该化合物处于临床试验阶段,尚未在多数地区取得上市许可。公开信息主要来自企业公告、学术会议摘要与试验注册平台记录,完整数据仍在逐步披露。关于长期疗效与安全性的判断,需要等待规模更大、随访更久的研究结果,目前不宜对最终结论作出预判。
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
| Property | Value | Notes |
|---|---|---|
| 分子类别 | 合成多肽 | 含非天然氨基酸与脂肪酸侧链 |
| 分子量 | 约 4.7 kDa | 多肽量级,精确值随计法而异 |
| 外观 | 白色至类白色冻干粉 | 常见冻干形态,供复溶使用 |
| 溶解性 | 易溶于水 | 复溶后为澄清至微乳光液体 |
| 常见同义词 | LY3437943 | 开发阶段使用的代号 |
Quality control of research material relies on several complementary checks. Purity testing confirms the absence of truncated or oxidized peptide species, while water content and counterion analysis show how much mass comes from salts rather than the peptide itself. Sequence verification through tandem mass spectrometry ensures the correct amino acid chain. Because unregulated suppliers vary widely, independent verification of identity and purity is often necessary before a sample enters experiments.
Documentation plays a practical role in maintaining consistent results across laboratories. Certificates of analysis list purity, identity, and testing methods, and batch numbers allow comparisons between lots. Records of storage temperature and handling history help investigators interpret unexpected findings. When a sample behaves anomalously, reviewing that documentation often reveals whether the cause lies in the material or in the assay conditions.
Mechanistic proposals link each receptor to a different physiological role. Activation of the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors is associated with reduced appetite, slower gastric emptying, and glucose-dependent insulin release. Glucagon receptor signaling, by contrast, is associated with increased energy expenditure and altered lipid handling, though it can also raise blood glucose. The design intent is to balance these contributions so that weight reduction is enhanced without unacceptable glycemic trade-offs. How well that balance holds across individuals is not fully resolved.
Published information places retatrutide in clinical development rather than on the market as an approved therapy. Early-stage and mid-stage trials have examined tolerability and changes in body weight, and larger studies continue to report results over time. Open questions include the durability of effects after treatment stops, the composition of weight lost, and cardiovascular outcomes over long periods. Statements about definitive benefit should therefore be treated as provisional. Regulatory status varies by jurisdiction and changes as applications are reviewed.
Retatrutide is an investigational synthetic peptide designed to activate three distinct receptor systems within a single molecule. Its pharmacological profile combines activity at the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This arrangement places it within a broader class of agents often described as multi-agonists, which contrast with compounds that engage one or two targets. Research interest centers on whether simultaneous signaling produces effects that single-receptor agonists cannot achieve alone. A single molecular entity also simplifies manufacturing and delivery logistics compared with combining separate agents.
In analytical chemistry, a standard solution (titrant or titrator) is a solution containing an accurately known concentration. Standard solutions are generally prepared by dissolving a solute of known mass into a solvent to a precise volume, or by diluting a solution of known concentration with more solvent. A standard solution ideally has a high degree of purity and is stable enough that the concentration can be accurately measured after a long shelf time. Making a standard solution requires great attention to detail to avoid introducing any risk of contamination that could diminish the accuracy of the concentration. For this reason, glassware with a high degree of precision such as a volumetric flask, volumetric pipette, micropipettes, and automatic pipettes are used in the preparation steps. The solvent used must also be pure and readily able to dissolve the solute into a homogenous solution. Standard solutions are used for various volumetric procedures, such as determining the concentration of solutions with an unknown concentration in titrations. The concentrations of standard solutions are normally expressed in units of moles per litre (mol/L, often abbreviated to M for molarity), moles per cubic decimetre (mol/dm3), kilomoles per cubic metre (kmol/m3), grams per milliliters (g/mL), or in terms related to those used in particular titrations (such as titres).
Cuprates have a structure close to that of a two-dimensional material. Their superconducting properties are determined by electrons moving within weakly coupled copper-oxide (CuO2) layers. Neighbouring layers contain ions such as lanthanum, barium, strontium, or other atoms that act to stabilize the structures and dope electrons or holes onto the copper-oxide layers. The undoped "parent" or "mother" compounds are Mott insulators with long-range antiferromagnetic order at sufficiently low temperatures. Single band models are generally considered to be enough to describe the electronic properties. The cuprate superconductors adopt a perovskite structure. The copper-oxide planes are checkerboard lattices with squares of O2− ions with a Cu2+ ion at the centre of each square. The unit cell is rotated by 45° from these squares. Chemical formulae of superconducting materials contain fractional numbers to describe the doping required for superconductivity. Several families of cuprate superconductors have been identified. They can be categorized by their elements and the number of adjacent copper-oxide layers in each superconducting block. For example, YBCO and BSCCO can be referred to as Y123 and Bi2201/Bi2212/Bi2223 depending on the number of layers in each superconducting block (n). The superconducting transition temperature peaks at an optimal doping value (p=0.16) and an optimal number of layers in each block, typically three. Possible mechanisms for cuprate superconductivity remain the subject of considerable debate and research.
Another bill allowed developers to build housing on some lots previously zoned exclusively for commercial use without getting local governments' permission if a certain percentage of the housing was affordable. A third bill allowed for the construction of market-rate housing on some lots previously zoned exclusively for commercial use. At the signing ceremony for the latter two bills, Newsom warned local governments, which have a history of blocking and delaying housing developments, that they would be held accountable for future housing obstructionism. Other bills he signed required localities "to approve or deny various building permits within a strict timeline" and streamlined student and faculty housing projects by allowing California colleges to skip onerous review processes for new projects. Measures and actions to reduce homelessness in California have not yet solved the problem. The number of homeless reached a record 181,000 in January 2023. According to some, to cope with this problem, California must build more than 2.5 million housing units.
=== Post-translational proteolytic processing === Limited proteolysis of a polypeptide during or after translation in protein synthesis often occurs for many proteins. This may involve removal of the N-terminal methionine, signal peptide, and/or the conversion of an inactive or non-functional protein to an active one. The precursor to the final functional form of protein is termed proprotein, and these proproteins may be first synthesized as preproprotein. For example, albumin is first synthesized as preproalbumin and contains an uncleaved signal peptide. This forms the proalbumin after the signal peptide is cleaved, and a further processing to remove the N-terminal 6-residue propeptide yields the mature form of the protein.
9-Carboxymethoxymethylguanine (CMMG) is a compound which is known as the principal metabolite of the antiviral medication aciclovir (and its prodrug valaciclovir), and has been suggested as the causative agent in the neuropsychiatric side effects sometimes associated with these medications. These are mainly suffered by patients with kidney failure or otherwise decreased kidney function, and can include psychotic reactions, hallucinations, and rarely more complex disorders such as Cotard delusion. Patients suffering these symptoms following aciclovir treatment were found to have much higher levels of CMMG than normal, and since this is the first time Cotard delusion has been linked to a drug as a side effect, this discovery may be useful in the study of Cotard delusion and its treatment.
Sources: en.wikipedia.org
Prolactin is a peptide hormone primarily produced in the anterior pituitary gland. Prolactin affects reproduction and lactation in humans and other non-human mammals. It is also thought to mediate the formation of social bonds between mothers and their infants, much like the hormone oxytocin. In addition to prolactin's role in the formation of social bonds, it is thought to be involved in romantic attachment, especially in its early stages. Prolactin may also act to mediate well-being and the positive effects of close relationships on one's health. To do so, it alters an individual's neuroendocrine system to increase the probability of forming a strong social bond without requiring long gestation periods; this may enable bonding between mother and child in cases of adoption. Prolactin can also influence both maternal and paternal behavior. The administration of prolactin to female rats initiates maternal behavior, and in bird and fish fathers, it can increase paternal behavior, whereas antagonists to prolactin decrease paternal behavior. In human studies, fathers with higher prolactin concentrations are more alert and nurturing towards their infants. In a different study where fathers and infants were observed over a six-months period after the child was born, the researchers found that fathers with higher prolactin levels were more likely to facilitate play with their infant. Moreover, following the birth of the child, prolactin promotes bonding between the father and the newborn. Prolactin levels can also increase during socially stressful situations in humans.
=== Later life and death === William H. Stein and his wife traveled around the world and hosted many prominent scientists in their own home in New York City throughout his scientific career. In addition to Stein's long-term professorship at Rockefeller Institute, he served as a visiting professor to the University of Chicago in 1961 and Harvard University in 1964. Stein also lectured at the Washington University in St. Louis and Haverford College. In 1969, Stein experienced sudden paralysis, diagnosed as Guillain–Barré syndrome, after developing a fever several days prior during a symposium in Copenhagen. Despite remaining quadriplegic the rest of his life, Stein's colleagues alleged that his spirit and sense of humor endured. He continued to be a guiding presence at the Rockefeller Institute to his younger colleagues and their work on the study of RNase. At the age of sixty-eight, Stein experienced unexpected heart failure. William H. Stein died February 2, 1980 in New York City.
== Mental health in the digital age == Digital technology has an increasing impact on mental health. Research suggests that constant online connection can increase stress, while digital tools may also expand access to mental-health support for people who cannot easily receive in-person care. Research also shows that digital media use can affect adolescents' emotional well-being, social development, and mental health outcomes. Cyberbullying and online harassment can worsen mental-health symptoms in children and adolescents. Studies show links between online bullying, depression, and anxiety as well as the long term impacts on individuals.
Soon arose the notion of a tranquilizer which was quite different from any sedative or stimulant. The term tranquilizer took over the notions of sedatives and became the dominant term in the West through the 1980s. In Japan, during this time, the term tranquilizer produced the notion of a psyche-stabilizer and the term mood stabilizer vanished. Premarin (conjugated estrogens, introduced in 1942) and Prempro (a combination estrogen-progestin pill, introduced in 1995) dominated hormone replacement therapy (HRT) regimens during the 1990s. Though not designed to cure any disease, HRT is prescribed to improve quality of life and as a preventative measure, such as treating post-menopausal symptoms. In the 1960s and early 1970s, more physicians began to prescribe estrogen for their female patients. Between 1991 and 1999, Premarin was listed as the most popular prescription and best-selling drug in America. The first oral contraceptive, Enovid, was approved by FDA in 1960. Oral contraceptives inhibit ovulation and so prevent conception. Enovid was known to be much more effective than alternatives including the condom and the diaphragm. As early as 1960, oral contraceptives were available in several different strengths by every manufacturer. In the 1980s and 1990s, an increasing number of options arose including, most recently, a new delivery system for the oral contraceptive via a transdermal patch. In 1982, a new version of "the pill" was introduced, known as the biphasic pill. By 1985, a new triphasic pill was approved.
== Detection by mass spectrometry == A mass spectrum of an organic compound will usually contain a small peak of one mass unit greater than the apparent molecular ion peak (M) of the whole molecule. This is known as the M+1 peak and comes from the few molecules that contain a 13C atom in place of a 12C. A molecule containing one carbon atom will be expected to have an M+1 peak of approximately 1.1% of the size of the M peak, as 1.1% of the molecules will have a 13C rather than a 12C. Similarly, a molecule containing two carbon atoms will be expected to have an M+1 peak of approximately 2.2% of the size of the M peak, as there is double the previous likelihood that any molecule will contain a 13C atom. In the above, the mathematics and chemistry have been simplified. However it can be used effectively to give the number of carbon atoms for small- to medium-sized organic molecules. In the following formula, the result should be rounded to the nearest integer:
Sources: en.wikipedia.org
指同一个分子能激活 GIP、GLP-1 和胰高血糖素三类受体。它与只激活一到两种受体的同类分子在设计思路上有所区别。这种设计的目的在于覆盖更多代谢调节通路。
天然肽类在体内容易被酶解并快速清除。脂肪酸侧链与非天然氨基酸可以延缓清除、降低酶解速率。修饰后的分子因此更适合较长间隔的给药安排。
公开资料主要来自临床阶段的报告与注册平台记录。这些材料提供的是阶段性信息,而非最终结论。完整的安全性与有效性数据仍在积累中。
It is a synthetic peptide triagonist that engages GIP, GLP-1, and glucagon receptors. Investigational compounds in this class are studied for metabolic conditions rather than for a single organ system.